Engineering ERα degraders with pleiotropic ubiquitin ligase ligands maximizes therapeutic efficacy by co-opting distinct effector ligases
1. 系统已在2025-12-21 20:27:52对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.chembiol.2025.04.008
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S245194562500131X
其他信息:
出版社: Elsevier BV
作者: Anna Shemorry; Willem den Besten; Melinda M. Mulvihill; Curt J. Essenburg; Nicole Blaquiere; Tracy Kleinheinz; Elisia Villemure; Frank Peale; Gauri Deshmukh; Danilo Maddalo; Elizabeth Levy; Kebing Yu; Matthew R. Steensma; Elizabeth A. Tovar; Emily Wolfrum; Karthik Nagapudi; Robert A. Blake; William F. Forrest; Steven T. Staben; Carrie R. Graveel; Wayne J. Fairbrother; Ingrid E. Wertz
